Country: United States
Language: English
Source: NLM (National Library of Medicine)
TULATHROMYCIN (UNII: Q839I13422) (TULATHROMYCIN - UNII:Q839I13422), KETOPROFEN (UNII: 90Y4QC304K) (KETOPROFEN - UNII:90Y4QC304K)
Zoetis Inc.
SUBCUTANEOUS
PRESCRIPTION
Draxxin® KP is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica , Pasteurella multocida , Histophilus somni , and Mycoplasma bovis , and control of pyrexia associated with BRD in beef steers, beef heifers, beef calves 2 months of age and older, beef bulls, dairy bulls, and replacement dairy heifers. Not for use in reproducing animals over one year of age, dairy calves, or veal calves. The use of DRAXXIN KP Injection is contraindicated in animals previously found to be hypersensitive to tulathromycin and ketoprofen. NOT FOR HUMAN USE. KEEP OUT OF REACH OF CHILDREN. The Safety Data Sheet (SDS) provides more detailed occupational safety information. To obtain a Safety Data Sheet contact Zoetis Inc. at 1-888-963-8471.
DRAXXIN KP Injection is available in the following package sizes: 50 mL vial 100 mL vial 250 mL vial 500 mL vial
New Animal Drug Application
DRAXXIN KP- TULATHROMYCIN AND KETOPROFEN INJECTION INJECTION, SOLUTION ZOETIS INC. ---------- DRAXXIN KP Draxxin® KP (tulathromycin and ketoprofen injection) INJECTABLE SOLUTION Antibiotic and Anti-inflammatory FOR SUBCUTANEOUS INJECTION 100 MG/ML TULATHROMYCIN + 120 MG/ML KETOPROFEN FOR SUBCUTANEOUS INJECTION ANTIBIOTIC: 100 mg of Tulathromycin/mL NON-STEROIDAL ANTI-INFLAMMATORY DRUG: 120 mg Ketoprofen/mL CAUTION Federal law restricts this drug to use by or on the order of a licensed veterinarian. DESCRIPTION DRAXXIN KP (tulathromycin and ketoprofen injection) Injectable Solution is a ready to use sterile parenteral preparation containing tulathromycin, a semi- synthetic macrolide antibiotic of the subclass triamilide and ketoprofen a non-steroidal anti-inflammatory drug. ACTIVE INGREDIENTS: Each mL of DRAXXIN KP contains 100 mg of tulathromycin as a free base and 120 mg ketoprofen as a free acid in a 50% propylene glycol vehicle. INACTIVE INGREDIENTS: monothioglycerol (5 mg/mL), 2-pyrrolidone (70 mg/mL), citric acid (20 mg/mL) and sodium hydroxide/hydrochloric acid added to adjust pH. DRAXXIN KP contains an equilibrated mixture of two isomeric forms of tulathromycin in a 9:1 ratio and a racemic mixture of ketoprofen. The structures of the tulathromycin isomers and ketoprofen are shown below: FIGURE 1. TULATHROMYCIN STRUCTURES ® The chemical names of the tulathromycin isomers are (2R,3S, 4R,5R,8R,10R,11R,12S, 13S,14R)-13-[[2,6-dideoxy-3-C-methyl-3-Ο-methyl-4-C-[(propylamino) methyl]-α-L-ribo- hexopyranosyl]oxy]-2-ethyl-3,4,10-trihydroxy-3,5,8,10,12, 14-hexamethyl-11-[[3,4,6- trideoxy-3-(dimethylamino)-β-D-xylohexopyranosyl]-oxy]-1-oxa-6-azacyclopentadecan- 15-one and (2R, 3R,6R,8R,9R,10S,11S,12R)- 11-[[2,6-dideoxy-3-C-methyl-3-Ο-methyl-4- C-[(propylamino)methyl]-α-L-ribohexopyranosyl]oxy]-2-[(1S,2R)-1,2-dihydroxy-1- methylbutyl]-8-hydroxy-3,6,8,10,12-pentamethyl-9-[[3,4,6-trideoxy -3-(dimethylamino)- β-D-xylo-hexopyranosyl]oxy]-1-oxa-4-azacyclotridecan-13-one, respectively. FIGURE 2. KETOPROFEN STRUCTURE Read the complete document